Eye Disease News and Research

RSS

Eye diseases are widespread around the globe. According to the World Health Organization, the most important three eye diseases or conditions that are a potential threat to the global population are diabetic retinopathy, glaucoma, and age-related macular degeneration. One more vital reason for visual harm is refractive errors. Some of the important reasons for vision loss or low vision are age, healthcare, gender, genetic problems and the prevalence of family history.

Researchers develop potential non-drug, non-surgical, long-acting therapy for glaucoma

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery with a twice-a-year injection to control the buildup of pressure in the eye.

7 Dec 2020

Study: Global public health services fail to meet targets to reduce avoidable sight loss

A new global study has found no significant reduction in the number of people with treatable sight loss since 2010.

3 Dec 2020

Studies examine rates of blindness and vision impairment worldwide

Sobering new statistics released by the Global Burden of Disease study found no significant reduction in the number of people with treatable sight loss worldwide since 2010 as public health services failed to meet World Health Organization (WHO) targets.

2 Dec 2020

New gene therapy approach offers promise for treating eye disease

Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe.

26 Nov 2020

Study finds diabetes epidemic among Xavante indigenous community in Central Brazil

The Xavante, one of the indigenous communities most vulnerable to SARS-CoV-2 in Brazil, are suffering from an epidemic of diabetes, a "silent" disease considered a risk factor for severe COVID-19.

10 Nov 2020

Common medication used to treat diabetic macular edema is less effective in Black patients

A medication frequently used to treat diabetic macular edema, which is the most common cause of blindness in people with diabetes, is less effective when used to treat the condition in Black patients, new study results show.

22 Oct 2020

Researchers create multi-functional nano-vaccine to prevent toxoplasmosis

Fighting clever parasites requires smart vaccines that can trigger critical immune responses. A University of Chicago-based research team has found a novel way to do that.

14 Oct 2020

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

Today, the U.S. Food and Drug Administration announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years.

8 Oct 2020

First pathoconnectome shows how eye disease alters retinal circuitry

Scientists from the John A. Moran Eye Center at the University of Utah have achieved another first in the field of connectomics, which studies the synaptic connections between neurons.

30 Sep 2020

Study reveals how people with retinal degenerative disease can maintain night vision

New insight on how people with retinal degenerative disease can maintain their night vision for a relatively long period of time has been published today in the open-access eLife journal.

22 Sep 2020

Biomarker for earlier diagnosis of neurodegenerative diseases detected in the eye

A new study led by Boston Medical Center researchers indicates a well-known biomarker that serves as a marker for earlier diagnosis of neurodegenerative diseases is now detectable in the eye.

21 Sep 2020

UC Davis uses microneedles to deliver gene therapy for retinal diseases

A novel approach to delivering gene therapy for retinal diseases eliminates the need for complex eye surgery and treats more damaged cells than existing methods, a team of UC Davis physicians and veterinary eye specialists has found.

16 Sep 2020

New guidelines can boost transparency of clinical trials evaluating AI health solutions

Patients could benefit from faster and more effective introduction of artificial intelligence (AI) innovations to diagnose and treat disease - thanks to the first international standards for reporting of clinical trials for AI.

10 Sep 2020

Fight for Sight partners with Diabetes UK to investigate link between eye disease and COVID-19

Eye research charity Fight for Sight is partnering with Diabetes UK to investigate if people with the eye disease diabetic retinopathy are at greater risk of developing complications from Covid-19, in a study that hopes to save lives.

8 Sep 2020

A collaborative team to develop new treatment for age-related macular degeneration

Karolinska Institutet and St. Erik Eye Hospital in Sweden have entered into a collaboration with Novo Nordisk A/S to develop a new treatment for age-related macular degeneration.

24 Aug 2020

Doctors with disabilities call for a paradigm shift to make medical education, profession more inclusive

Doctors treat and heal patients, but they are seldom seen as people who may themselves require care or accommodation. Medics with disabilities are now calling for a paradigm shift in this mindset to make medical education and the profession more inclusive.

21 Aug 2020

Eye Disease News and Research

Further Reading

Researchers develop potential non-drug, non-surgical, long-acting therapy for glaucoma

Study: Global public health services fail to meet targets to reduce avoidable sight loss

Studies examine rates of blindness and vision impairment worldwide

New gene therapy approach offers promise for treating eye disease

Study finds diabetes epidemic among Xavante indigenous community in Central Brazil

Common medication used to treat diabetic macular edema is less effective in Black patients

Researchers create multi-functional nano-vaccine to prevent toxoplasmosis

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

First pathoconnectome shows how eye disease alters retinal circuitry

Study reveals how people with retinal degenerative disease can maintain night vision

Biomarker for earlier diagnosis of neurodegenerative diseases detected in the eye

UC Davis uses microneedles to deliver gene therapy for retinal diseases

New guidelines can boost transparency of clinical trials evaluating AI health solutions

Fight for Sight partners with Diabetes UK to investigate link between eye disease and COVID-19

A collaborative team to develop new treatment for age-related macular degeneration

Doctors with disabilities call for a paradigm shift to make medical education, profession more inclusive

Nanoparticle carriers expand the effectiveness of gene therapies for human eye diseases

SPT enzyme can be used as metabolically responsive “switch” to slow tumor growth

Immune system's oldest branches may underpin COVID severity

Study uncovers dual role for molecule involved in autoimmune eye disease

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News